Interleukin-1 and its biologically related cytokines.
Dinarello
C A
CA
Department of Medicine, Tufts University School of Medicine, Boston, Massachusetts 02111.
D000209:Acute-Phase Proteins / Q000096:biosynthesis; D001685:Biological Factors / Q000235:genetics / Q000502:physiology; D016207:Cytokines; D004727:Endothelium / Q000187:drug effects; D005347:Fibroblasts / Q000187:drug effects / Q000378:metabolism; D005786:Gene Expression Regulation; D006801:Humans; D007249:Inflammation; D007375:Interleukin-1 / Q000235:genetics / Q000494:pharmacology / Q000502:physiology; D015850:Interleukin-6; D007378:Interleukins / Q000502:physiology; D007694:Killer Cells, Natural / Q000187:drug effects; D007963:Leukocytes, Mononuclear / Q000378:metabolism; D008099:Liver / Q000187:drug effects / Q000378:metabolism; D008213:Lymphocyte Activation; D008214:Lymphocytes / Q000187:drug effects / Q000276:immunology; D011971:Receptors, Immunologic / Q000502:physiology; D017472:Receptors, Interleukin-1; D015398:Signal Transduction; D013582:Synovial Fluid / Q000378:metabolism; D014409:Tumor Necrosis Factor-alpha / Q000502:physiology
D000209:Acute-Phase Proteins; D001685:Biological Factors; D016207:Cytokines; D007375:Interleukin-1; D015850:Interleukin-6; D007378:Interleukins; D011971:Receptors, Immunologic; D017472:Receptors, Interleukin-1; D014409:Tumor Necrosis Factor-alpha